Jeremy Katcher, MD
Allergy & Immunology · Saint Louis, MONPI 1124235239
Payments from drug & device makers
Across 459 payments — averaging $34.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$4K
- Novartis$2K
- AstraZeneca$2K
- Teva Pharmaceuticals USA, Inc.$2K
- GSK$794
- CSL Behring$568
- plus $4K from 28 others
Across 16 payments — averaging $145.49 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- GSK$2K
What the payments were for
- Consulting fees$4,46728%
- Speaking & faculty fees$2,05513%
- Food & beverage$9,09958%
- Education$921%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 34 | $4,072 |
| Novartis | 14 | $2,388 |
| AstraZeneca | 102 | $1,872 |
| Teva Pharmaceuticals USA, Inc. | 12 | $1,837 |
| GSK | 61 | $794 |
| CSL Behring | 30 | $568 |
| Kaleo, Inc. | 25 | $423 |
| Alk-abello, Inc | 9 | $410 |
| Takeda Pharmaceuticals U.S.A., Inc. | 36 | $392 |
| Pfizer | 23 | $375 |
| Aimmune Therapeutics, Inc. | 7 | $296 |
| Shire North American Group Inc | 7 | $270 |
| Genentech USA, Inc. | 14 | $252 |
| Watermark Medical, Inc. | 1 | $207 |
| Covis Pharma GmbH | 9 | $179 |
| Regeneron Healthcare Solutions, Inc. | 8 | $161 |
| Grifols USA, LLC | 9 | $156 |
| Bio Products Laboratory USA, Inc. | 10 | $147 |
| Optinose US, Inc. | 9 | $142 |
| Genentech, Inc. | 2 | $103 |
| Amgen(2 entities) | 7 | $101 |
| Boehringer Ingelheim | 7 | $101 |
| ADMA Biomanufacturing LLC | 5 | $89 |
| Incyte Corporation | 3 | $87 |
| Biocryst US Sales Co., LLC | 4 | $81 |
| Regeneron | 1 | $43 |
| Merck | 3 | $41 |
| Sanofi-aventis U.S. LLC | 1 | $24 |
| AbbVie | 1 | $22 |
| Chiesi USA, Inc. | 1 | $18 |
| Eyevance Pharmaceuticals LLC | 1 | $16 |
| Stryker | 1 | $15 |
| Pharming Healthcare, Inc. | 1 | $15 |
| Novo Nordisk | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DUPIXENT$1,817
- ArmonAir Digihaler$1,680
- AirDuo RespiClick$1,680
- ProAir Digihaler$1,680
- Odactra$308
- Ragwitek$308
- Grastek$308
- ARES HOME SLEEP TESTING DEVICE$207
- TIMOTHY, STANDARDIZED$185
- PALFORZIA$175
- Rhapsido$135
- WAYRILZ$127
- FASENRA$125
How this compares
$15,713 in reported general payments places this provider in the 70th percentile of 61 allergy & immunology providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 43 | $168,443 |
| Gammagard LiquidImmun Glob G(Igg)/Gly/Iga Ov50 | 11 | $97,143 |
| XolairOmalizumab | 22 | $82,928 |
| SymbicortBudesonide/Formoterol Fumarate | 40 | $9,151 |
| Advair HfaFluticasone Propion/Salmeterol | 12 | $3,901 |
| Epinephrine | 24 | $3,760 |
| Azelastine Hcl | 97 | $2,487 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 12 | $2,369 |
| Mometasone Furoate | 14 | $1,932 |
| Olopatadine Hcl | 14 | $1,711 |
| Fluticasone Propionate | 80 | $1,120 |
| Montelukast Sodium | 70 | $727 |
| Ipratropium Bromide | 30 | $491 |
| Gabapentin | 22 | $361 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 22 | $236 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc.Gammagard Liquid | $392 | $97,14311 claims |
| Genentech, Inc.Xolair | $103 | $82,92822 claims |
| AstraZenecaSymbicort | $1,872 | $9,15140 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 61 allergy & immunology providers in Missouri.
Other allergy & immunology in Saint Louis
- Jeffrey TillinghastSaint Louis$11M
- H James WednerSaint Louis$2.3M
- Peggy KendallSaint Louis$895K
- Barbara JostSaint Louis$470K
- Phillip KorenblatSaint Louis$453K
- Manoj WarrierSaint Louis$316K
- Maya JerathSaint Louis$129K
- Jennifer MonroySaint Louis$123K
- Aaron Ver HeulSaint Louis$100K
- Zhen RenSaint Louis$45K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.